Skip to main content

Table 1 Criteria for exclusion reported during the enrollment period

From: Risk of hyperkalemia in patients with moderate chronic kidney disease initiating angiotensin converting enzyme inhibitors or angiotensin receptor blockers: a randomized study

Declined to participate

(n = 26)

Secondary arterial hypertension

(n = 5)

Previous allergic reaction to ACEIs

(n = 3)

Previous allergic reaction to ARBs

(n = 2)

Active disease in other organs

(n = 6)

Previous gastrointestinal surgery

(n = 1)

Diseases causing malabsorption

(n = 1)

Recent (1 year) ischemic episodes

(n = 9)

History of ventricular arrhythmias

(n = 2)

History of cardiac insufficiency

(n = 8)

Current prescription with diuretics

(n = 9)

Current prescription with potassium

(n = 4)

Current prescription with B-blockers

(n = 7)

Current prescription with NSAIDs

(n = 3)

  1. ACEIs: Angiotensin-converting enzyme inhibitors, ARBs: Angiotensin receptor blockers, NSAIDs: nonsteroidal anti-inflammatory drugs, B-blockers: Beta-blockers.